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Abstract
Background: Loss to follow-up (LTF) after antiretroviral therapy (ART) initiation is common in HIV clinics. We examined the
effect of availability of adherence support and active patient outreach services on patient attrition following ART initiation.
Methods and Findings: This ecologic study examined clinic attrition rates (total attrition, LTF, and death) among 232,389
patients initiating ART at 349 clinics during 2004–2008 in 10 sub-Saharan African countries, and cohort attrition (proportion
retained at 6 and 12 months after ART initiation) among a subset of patients with follow-up information (n = 83,389). Loglinear regression compared mean rates of attrition, LTF, and death between clinics with and without adherence support and
outreach services. Cumulative attrition, LTF, and death rates were 14.2, 9.2, and 4.9 per 100 person-years on ART,
respectively. In multivariate analyses, clinic availability of .2 adherence support services was marginally associated with
lower attrition rates (RRadj = 0.59, 95%CI: 0.35–1.0). Clinics with availability of counseling services (RRadj = 0.62, 95%CI: 0.42–
0.92), educational materials (RRadj = 0.73, 95%CI: 0.63–0.85), reminder tools (RRadj = 0.79, 95%CI: 0.64–0.97), and food rations
(RRadj = 0.72, 95%CI: 0.58–0.90) had significantly lower attrition, with similar results observed for LTF. Outreach services were
not significantly associated with attrition. In cohort analyses, attrition was significantly lower at clinics offering .2
adherence support services (RRadj,6m = 0.84, 95%CI: 0.73–0.96), dedicated pharmacy services (RRadj,6m = 0.78, 95%CI: 0.69–
0.90), and active patient outreach (RRadj,6m = 0.85, 95%CI: 0.73–0.99). Availability of food rations was marginally associated
with increased retention at 6 (RRadj,6m = 0.82, 95%CI: 0.64–1.05) but not 12 months (RRadj,12m = 0.98, 95%CI: 0.78–1.21).
Conclusions: Availability of adherence support services, active patient outreach and food rations at HIV care clinics may
improve retention following ART initiation.
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coupled with food insecurity[10,12–14], and stigma [10–13] may
improve retention by increasing survival and reducing LTF, but
their effectiveness in a diverse service delivery context is largely
unknown. Two studies in resource-limited settings have found
active outreach associated with lower LTF and more complete
vital status ascertainment [15,16].
This study used routinely-collected aggregate (ecologic) data
collected from HIV care and treatment clinics in 10 sub-Saharan
African countries to investigate whether the availability of clinic
services targeting adherence to ART medication and retention in
care was associated with better retention after ART initiation.

Introduction
Adherence to antiretroviral therapy (ART) and long-term
retention in care is essential for optimal treatment outcomes.
Identifying modifiable clinic-level factors associated with patient
retention and survival may suggest feasible points of intervention.
Two reviews of patients initiated on ART in sub-Saharan Africa
reported high non-retention six (12%–45%) and 12 (10%–51%)
months after ART initiation with substantial variability across
clinics [1,2]. Studies tracing patients lost to follow-up (LTF) have
found high unascertained deaths and transfers [3–5], suggesting
both contribute substantially to LTF.
Services focusing on barriers to medication and care adherence,
including forgetfulness [6–10], lack of knowledge about the
importance of adherence [6–12], fear of increased appetite
PLoS ONE | www.plosone.org

1

June 2012 | Volume 7 | Issue 6 | e38443

Attrition after ART Initiation, Sub-Saharan Africa

defined as having no clinic visit in 3 months without documented
evidence of death or transfer to another clinic. In the cumulative
analysis, patients considered LTF as per above definition who
return to ART care were no longer considered LTF, while in the
cohort analysis such patients were LTF at 6 and 12 months
regardless of whether they subsequently returned thereafter to
ART care. Patients were classified as having died based on
information passively received by each clinic; no deaths were
independently ascertained.
Cumulative rates (attrition, LTF, death). Clinic persontime on ART during each quarter was calculated by allotting 3
months of person-time for each patient on ART at the beginning
of a given quarter, and 1.5 months for patients initiating ART or
discontinuing ART (death, transfer, LTF, stopping ART) during
the quarter. Thus, all attrition and ART initiation was assumed to
occur at the middle of each quarter. These person-months were
summed across all quarters through December 2008 to obtain
cumulative clinic person-time on ART. Total attrition, death, and
LTF rates were computed by dividing the cumulative number of
attritions, deaths, or LTF, respectively, by the cumulative clinic
person-time on ART for each clinic. Rates through December
2008 were expressed per 100 person-years on ART. Figure 1
describes the method used to calculate clinic-level attrition, LTF,
and death rates using the example of total attrition.
For example, if 100 patients were active on ART at the
beginning of the study period (N0 in Figure 1, 25, 30, 35, and 30
patients newly initiated ART in Quarters 1, 2, 3, and 4,
respectively, and the total attrition was 5, 10, 15, and 10 patients
during Quarters 1, 2, 3, and 4, respectively, while there were no
transfers during this period, our cumulative attrition rate for this
clinic is calculated as:
Total attrition = Sum(Att1 to Att4) = 5+10+15+10 = 40 patients
PM1 = 100patients*3months + 25patients*1.5months
– 5patients*1.5months = 330 person- months
PM2 = 120patients*3months + 30patients*1.5months
– 10patients*1.5months = 390 person-months
PM3 = 140patients*3months + 35patients*1.5months
– 15patients*1.5months = 450 person-months
PM4 = 160patients*3months + 30patients*1.5months
– 10patients*1.5months = 510 person-months
Cumulative attrition rate = 40/(330+390+450+510)
= 28.6 per 100 person-years

Methods
Study Population
All HIV care and treatment programs supported by the U.S.
President’s Emergency Plan for AIDS Relief (PEPFAR) are required
to report to the U.S. Government aggregate data summarizing
characteristics of patients receiving HIV care and treatment at these
clinics. Our study used aggregate (ecologic) clinic-level information
from HIV-positive patients receiving antiretroviral therapy at clinics
supported by ICAP-Columbia University in 10 sub-Saharan African
countries (Cote d’Ivoire, Ethiopia, Kenya, Lesotho, Mozambique,
Nigeria, Rwanda, South Africa, Tanzania, Zambia) were included.
Each clinic is governed by national HIV care guidelines and provides
free ART. Information on clinic characteristics was collected for
routine monitoring and evaluation purposes by ICAP-staff through
interviews conducted with clinic staff. No patient-level information
was used in this study. The use of these routine monitoring and
evaluation data for this study was approved as nonhuman subjects
research by the US Centers for Disease Control and Prevention
(CDC) and the Institutional Review Board of Columbia University
Medical Center.
We included clinics providing ART services during January
2004–December 2008 that reported quarterly care and treatment
indicators for at least three consecutive quarters and completed a
site assessment survey. Of the 392 clinics supported by ICAP
during 2004–2008, 349 (89%) were included, representing over
232,000 patients initiating ART. Six and 12 month follow-up data
were also available on 1,097 cohorts of patients (N = 83,389)
initiating ART in 3 month quarterly calendar periods, and were
included in cohort analyses to assess retention on ART.

Data Sources
Three sources of data were used: (1) cumulative clinic-level data on
the number of patients initiating ART, LTF, and reported as having
died or transferred (reported quarterly); (2) cohort-level data on the
proportion of persons initiating ART in a quarter who remained on
ART six- and 12-months after ART initiation (also reported
quarterly), and (3) a structured survey administered to clinic staff
measuring clinic-level characteristics.
Aggregate clinic-level outcome data. Aggregate clinic-level
data were obtained from routinely-collected PEPFAR Track 1.0
quarterly program indicators, manually tallied fromregisters by clinic
staff. Each clinic has a paper-based patient register provided by the
country Ministry of Health, on which visit date information is
captured. Clinic staff record patients who transfer to another clinic as
‘‘transfers out’’, and those not seen for more than three months as lost
to follow-up on these forms; LTF patients who return to care will have
their LTF designation removed from the register. Separate ‘‘ART
registers’’ are tabulated by clinic data clerks to retrospectively assess
whether patients initiating ART 6 and 12 months ago are alive and on
ART during the current quarter.
Program-level exposure data. Availability of adherence
support and outreach services at each clinic, along with
information on the context in which each clinic operates, was
obtained from structured surveys administered by field staff in
June 2007, December 2007, and July 2008. Test-retest agreement
assessed for a subset of survey items at 58 clinics included in this
analysis was 83% overall (79% for adherence support questions,
74% for the outreach question) (data not presented).

Cohort attrition 6 and 12 months following ART
initiation. Data on 6 and 12 month attrition was derived from

a subset of patients (83,389 of the 232,000 total patients) from
1,097 three-month cohorts of patients initiating ART. Cohorts
were included if data were available at both 6 and 12 months after
ART initiation, and cohort attrition was defined as the proportion
of patients not alive and on ART 6 and 12 months after ART
initiation at a given clinic.

Clinic Adherence and Outreach Services
Annual structured site assessments conducted at each clinic
captured information on clinic staffing and the availability of
support services. For this analysis, we focused on support services
targeting adherence to antiretroviral therapy and retention in care.
Clinics were queried on availability of the following categories of
adherence support services: ‘‘directed support services’’ involving
interaction with clinic staff (one-on-one or group adherence
counseling, on-site support groups, peer educator programs),
‘‘informational services’’ (written educational materials, reminder
tools), ‘‘pharmacy services’’ (routine medication pickup review,
presence of a dedicated ART pharmacist), and ‘‘structural
services’’ (food rations to support ART adherence). Each service

Outcome Definitions
Attrition was defined as the sum of patients initiating ART who
were reported: 1) dead, 2) LTF, or 3) discontinued ART (even if
they remained in HIV care) during the reporting period. LTF was
PLoS ONE | www.plosone.org
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Figure 1. Schematic calculation of clinic-level attrition, LTF, and death rates using aggregate data. Ni = Number of patients active on
ART at the end of reporting quarter i. Newi = Number of patients newly initiating ART during reporting quarter i. Atti = Number of patients
attritioned (discontinued ART, lost to follow-up, or dead) during quarter i. Ti = Number of patients transferring to another clinic during quarter i.
doi:10.1371/journal.pone.0038443.g001

was dichotomized according to reported availability at clinic.
Additionally, the total number of adherence support services
available at a given clinic (dichotomized at the lower quintile of
prevalence into .2 vs. #2) was constructed. Clinics reporting the
presence of a system to trace patients missing scheduled visits via
telephone, letters, or home visits were classified as having active
outreach.

57% were located in semi-urban or urban areas (Table 1). Kenya
contributed the most number of clinics (N = 71 [20%]), while
Mozambique contributed the most number of patients (N = 53,000
[23%]). Overall, 59% of the adults were female and 8% were
pediatric patients ,15 years of age.

Adherence Support and Outreach Services
Almost all clinics (93%) reported availability of at least one
adherence support service and 83% reported more than two; 53%
reported availability of active patient outreach (Table 2). Clinics
averaged availability of four adherence support services; specific
service availability at clinics ranged from 17% (food rations) to
88% (one-on-one and/or group counseling). Table 3 presents
cross-tabulated proportions showing the joint distribution of
adherence support and outreach services within the same facilities.
We found that adherence support services were not randomly
distributed across clinics. Rather, clinics with one service tended to
be more likely to have other services as well, although there is
substantial heterogeneity between clinics.

Statistical Analyses
Cumulative clinic rates of total attrition, LTF, and death, as well
as 6 and 12 month attrition proportions for cohorts initiating
ART, were assessed in relation to clinic availability of adherence
and outreach services. Adjustments were made for clinic
characteristics thought to be plausibly associated with patient
outcomes (clinic population (cumulative number of patients
enrolled in care), location (urban/rural), facility type (primary,
secondary, tertiary), year of HIV program start, and year of ART
initiation (for cohort analyses)).
Log-linear models were used to estimate cumulative attrition,
LTF, and death rate ratios comparing clinics with and without
availability of each adherence support and outreach service. Both
unadjusted and adjusted models controlling for clinic characteristics listed above were fit. Next, a ‘‘full’’ model was constructed to
assess the joint influence of each adherence and active outreach
service associated with the outcome of interest at alpha level #0.1.
For 6 and 12 months cohort attrition, risk ratios comparing
mean attrition proportions of cohorts at 6 and 12 months after
ART initiation were modeled using log-linear regression accounting for within-site correlation following methods described above.
A series of sensitivity analyses were conducted on our
cumulative and ART cohort analyses excluding years of data
collection and individual countries to estimate the influence on our
measures of association. These sensitivity analyses follow the same
procedures outlined above.

Outcomes
Of the 232,389 patients initiating ART during 2004- December
2008, 72% were still active on ART and attending the same clinic
at the end of the follow-up period. Of those no longer active on
ART as of December 2008, 20,348 (9%) transferred to another
clinic and attrition occurred among 44,428 (19%), including
14,678 (6.3%) who died, 2,148 (0.9%) discontinuing ART, and
27,602 (11.9%) LTF. The overall total attrition rate (measured as
specified in Figure 1) was 14.2 per 100 person-years (4.9 deaths,
0.7 discontinuations, and 9.2 LTF per 100 person-years). Among
the 6 and 12 month ART cohorts, attrition proportion were 20%
and 27%, respectively among the 82,981 patients included.

Total Attrition
In multivariate analyses (Table 4), clinics with .2 vs. #2
adherence support services available had marginally lower
attrition (RRadj = 0.59, 95%CI: 0.35–1.0). For specific adherence
services, availability of educational materials (RRadj = 0.73,
95%CI: 0.63–0.85), one-on-one and/or group adherence coun-

Results
232,000 patients initiated ART from 349 clinics in 10 countries
and were followed for 300,700 person-years. Most clinics were
situated at primary (47%) or secondary (48%) health facilities, and
PLoS ONE | www.plosone.org
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2003

(26.9%)

(16.9%)

(21.2%)

(20.9%)

(11.7%)

(2%)

8,992

20,042

39,457

72,391

76,924

14,583

Year site initiated ART care (site-level), or year cohort initiated ART (cohort-level)

149
114

Rural

(42.7%)

(4.0%)

14

Facility Location

Tertiary

Secondary

(46.7%)
(48.1%)

163
168

Primary

Facility Type

(12.3%)

(12.6%)

(7.7%)

(11.2%)

(0.3%)

39

Mozambique

(7.4%)

1

26

Lesotho

(20.3%)

(12.6%)

(12.9%)

71

Kenya

(2.6%)

45

44
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9

Cote d’Ivoire

General Facility Characteristics

136,999
18,696

Pediatric

232,389

Adult Female

(100%)
213,693

349

Adult

Total
(100%)

(3.9%)

(8.6%)

(17%)

(31.2%)

(33.1%)

(6.3%)

(47.9%)

(38.9%)

(13.1%)

(9.8%)

(68.9%)

(21.3%)

(0.2%)

(8.3%)

(16.2%)

(8.5%)

(8.4%)

(22.9%)

(7.8%)

(11.2%)

(16.1%)

(0.4%)

(8%)

(59%)

(92%)

(63%)

1,097

(100%)

n.a

n.a

n.a

n.a

65
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79

12

122

85

.

21

31

39

12

36

11

33

38

(29.0%)

(34.0%)

(36.0%)

(5.4%)

(55.2%)

(38.5%)

.

(9.5%)

(14.0%)

(17.7%)

(5.4%)

(16.3%)

(5.0%)

(14.9%)

(17.2%)

700

333

58

6

–

–

410

333

341

88

646

354

.

84

148

240

36

196

36

113

244

(63.8%)

(30.4%)

(5.3%)

(0.5%)

(37.4%)

(30.4%)

(31.1%)

(8%)

(58.9%)

(32.3%)

(7.7%)

(13.5%)

(21.9%)

(3.3%)

(17.9%)

(3.3%)

(10.3%)

(22.2%)

Median CD4 count at ART initiation:

221

N (%) Facilities

N (%) cohorts

N (%) facilities
with cohorts

Cum N (%) patients on ART

12-month Cohort-level Characteristics

Facility-Level Characteristics

Table 1. Facility and cohort-level characteristics of study population.

52,366

26,145

4,747

132

–

–

49,228

23,519

9,850

10,842

56,978

14,829

.

6,217

8,961

8,334

5,873

23,023

4,362

6,410

20,212

134 (109–171)

83,389

(62.8%)

(31.4%)

(5.7%)

(0.2%)

(59%)

(28.2%)

(11.8%)

(13%)

(68.3%)

(17.8%)

(7.5%)

(10.7%)

(10%)

(7%)

(27.6%)

(5.2%)

(7.7%)
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N (%) patients in cohorts
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48 (20–105)

61 (31–100)
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–

–
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24 (15–36)

113 (46–192)
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24 (13–50)

.

56 (32–91)

47 (21–84)
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72 (28–186)
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median (q1–q3)
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cohort per facility
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Active patient outreach

Outreach Services

Food rations to promote ART adherence

Structural services

Routine medication pickup review, dedicated or team
pharmacist

Pharmacy Services

Reminder tools (e.g., clocks, calendars, pill boxes)

Educational materials promoting ART adherence

Informational services

peer educator program

on-site support groups
for HIV+ patients

one-on-one/group adherence counseling

Directed support services

Any adherence support program

Adherence support and related services

Overall
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308
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465 396

232,389

(72.5%)

(27.5%)

(14.7%)

(85.3%)

(96%)

(4%)

(88.2%)

(11.8%)

(63%)

(37%)

(54.8%)

(45.2%)

(73.1%)

(26.9%)

(96.8%)

(3.2%)

(99.7%)

(0.2%)

(100%)

Cum N (%) patients on ART

Facility-Level Characteristics

Table 2. Facility and cohort-level exposure and outcome characteristics.
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363

178

919

1,027

61

978

110

773

315

476

612

679

409

685

403

1082

1

1,097

(66.1%)

(33.1%)

(16.2%)

(83.8%)

(93.6%)

(5.6%)

(89.2%)

(10%)

(70.5%)

(28.7%)

(43.4%)

(55.8%)

(61.9%)

(37.3%)

(62.4%)

(36.7%)

(98.6%)

(0.1%)

(100%)

Number (%) of cohorts

57,611

25,037

7,311

76,078

79,428

3,220

74,805

7,844

56,070

26,578

45,534

37,115

58,411

24,238

51,701

30,947

82611

10

83,389

(69.1%)

(30%)

(8.8%)

(91.2%)

(95.3%)

(3.9%)

(89.7%)

(9.4%)

(67.2%)

(31.9%)

(54.6%)

(44.5%)

(70%)

(29.1%)

(62%)

(37.1%)

(99.1%)

(0%)

(100%)

50 (22–105)

44 (21–83)

27 (17–57)

53 (23–109)

49 (23–99)

24 (12–55)

49 (22–99)

33 (17–82)

47 (23–94)

49 (18–110)

61 (26–128)

39 (19–80)
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38 (18–74)

48 (21–94)

48 (21–99)

48 (22–96)

10 (10–10)

48 (21–96)

median (q1–q3)
Number (%) of patients in patients per cohort
cohorts
per site

Cohort-level Characteristics (N = 221 facilities with cohorts)
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86%
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Active patient outreach

100%

55%

97%

68%

Yes

No

78%
97%

Yes

No

85%
96%

Yes

No

84%
93%

No

Yes

92%

21%

3%

11%

0%

45%

3%

32%

3%

22%

4%

15%

7%

16%

8%

26%

80%

50%

75%

41%

58%

38%

61%

50%

58%

34%

81%

37%

No

Yes

57%

Yes

Food rations to promote ART Yes
adherence

Routine medication pickup
review/dedicated pharmacist

Reminder tools

Educational materials

Peer educators

On-site support groups
for HIV+ patients

Adherence counseling

74%

20%

50%

25%

59%

42%

62%

39%

50%

42%

66%

19%

63%

43%

No

Yes

Yes

No

On-site support
groups for HIV+
patients

Adherence
counseling

18%

65%

37%

73%

32%

46%

29%

49%

36%

48%

18%

64%

73%

45%

Yes

82%

35%

63%

27%

68%

54%

71%

51%

64%

52%

82%

36%

27%

55%

No

Peer educators

Table 3. Cross-tabulated frequency of adherence support and outreach services.

46%

66%

50%

92%

15%

68%

26%

70%

52%

64%

52%

61%

20%

62%

Yes

54%

34%

50%

8%

85%

32%

74%

30%

48%

36%

47%

39%

80%

37%

No

Educational
materials

55%

83%

67%

87%

27%

81%

49%

86%

63%

80%

60%

79%

20%

77%

Yes

45%

17%

33%

13%

73%

19%

51%

14%

37%

20%

40%

21%

80%

23%

No

Reminder tools

68%

89%

76%

98%

50%

92%

60%

94%

76%

85%

74%

85%

22%

87%

Yes

32%

11%

24%

2%

50%

8%

40%

6%

24%

15%

26%

15%

78%

13%

No

Routine
medication
pickup review/
dedicated
pharmacist

1%

32%

1%

21%

8%

21%

3%

28%

8%

29%

9%

24%

0%

19%

Yes

99%

68%

99%

79%

92%

79%

97%

72%

92%

71%

91%

76%

100%

81%

No

Food rations to
promote ART
adherence

44%

98%

27%

60%

30%

63%

41%

62%

32%

81%

23%

78%

15%

58%

Yes

56%

2%

73%

40%

70%

37%

59%

38%

68%

19%

77%

22%

85%

42%

No

Active patient
outreach
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not 6 months. Availability of food rations was not associated with 6
or 12 month attrition among cohorts of patients initiating ART.
Sensitivity analyses for both clinic- and cohort-level models
examining the impact of excluding the first year of data collection,
and separately excluding individual countries, were conducted to
assess the robustness of our findings. These analyses found no
substantial differences in the magnitude of point estimates,
although variability increased somewhat due to a reduced sample
size (data not shown).

seling (RRadj = 0.62, 95%CI: 0.42–0.92), reminder tools
(RRadj = 0.79, 95%CI: 0.64–0.97), and food rations to support
ART adherence (RRadj = 0.72, 95%CI: 0.58–0.90) were significantly associated with lower attrition rates (Table 4). On-site
support groups, peer educator programs, pharmacy support
services and active patient outreach were not significantly
associated with attrition following ART initiation.

Loss to Follow-up
In multivariate analyses, clinics with .2 vs. #2 adherence
support services available had lower rates of LTF (RRadj = 0.48,
95%CI: 0.25–0.92). For specific services, availability of educational materials (RRadj = 0.63, 95%CI: 0.52–0.77) and adherence
counseling (RRadj = 0.55, 95%CI: 0.33–0.89) was significantly
associated with lower rates of LTF. Availability of pharmacy
services including routine medication pickup review (RRadj = 0.60,
95%CI: 0.36–1.0) was marginally associated with LTF, as was
availability of food rations (RRadj = 0.65, 95%CI: 0.47–0.88).
Other service availability was not significantly associated with
LTF.

Discussion
Most studies of adherence support interventions to date have
focused on interventions supporting medication adherence among
those receiving antiretroviral medications [14,17–24]. The focus of
this report aims at addressing the related and upstream issue of
retention of patients after initiation of ART, in recognition of the
importance of attrition in the context of large scale HIV programs,
which remains suboptimal [1,2,9,25–27]. Our findings demonstrate that clinics with educational materials and food rations
available were significantly associated with lower attrition and
lower LTF compared with clinics without these services, while
clinics with availability of support groups, peer educators and
reminder tools for adherence were associated with lower rates of
measured death compared to clinics without these services. In
ART cohort analyses, pharmacy support was significantly
associated with lower 6 month attrition, and active outreach was
associated with lower 12 month attrition. These findings were
observed across clinics from diverse settings in sub-Saharan Africa
independent of other clinic characteristics (urban/rural, facility
type [primary, secondary, tertiary], patient load, and program
maturity).
Studies from sub Saharan Africa have attempted to better
define the outcomes of patients lost to follow-up. In our analyses,
65% of the observed attrition rate was due to LTF. A 2009 review
of studies tracing patients LTF from resource-limited settings
estimated that between 33–48% of such patients classified as LTF
had actually died, with substantial variability across studies and
populations [3]. Other studies have found substantial contributions from both undocumented deaths and undocumented
transfers to LTF [4,5,26,28–35]. This heterogeneity underscores
that there are many, perhaps divergent, reasons why patients
become LTF [36]. A key issue is the contribution of unascertained
death to losses to follow-up [4–6]. If clinics with higher LTF rates
are consequentially reporting proportionately fewer ‘‘true’’ deaths,
this would mask the relationship between service availability and
actual death through differential death reporting. Consequently, in
settings experiencing high loss to follow-up, we recommend using
the combined outcome of total attrition as the primary measure of
patient outcomes when using aggregate data. When using
individual-level data, nomogram approaches can be used for
correcting mortality rates for loss to follow-up [37,38].
In our analyses, we noted several discrepancies that may reflect
this complex interplay. Clinics with availability of educational
materials, one-on-one/group counseling, and reminder tools had
significantly lower rates of attrition and LTF, but were not
associated with measured death rates. In addition, clinics with
availability of support groups and peer educators had significantly
lower death rates but did not have lower rates of attrition or LTF.
Differentially lower ascertainment of the true number of deaths
among clinics offering these services (due to higher LTF in these
clinics) may partially explain these findings. Complete ascertainment of causes of LTF is necessary in order to better understand
the associations identified in our analyses [39]. Barring this,

Deaths
In multivariate analyses (Table 4), availability of .2 vs. #2
adherence support services was not associated with reported death
rates. Among specific adherence services, availability of on-site
support groups (RRadj = 0.81, 95%CI: 0.70–0.93), peer educators
(RRadj = 0.84, 95%CI: 0.74–0.96) and reminder tools
(RRadj = 0.81, 95%CI: 0.66–0.98) were significantly associated
with lower death rates, while availability of food rations to support
ART adherence was marginally associated with lower death rates
(RRadj = 0.83, 95%CI: 0.69–1.0). Availability of adherence counseling, educational materials, and pharmacy services were not
significantly associated with death rates at clinics.

Attrition in 6 and 12 Month Cohorts
In multivariate analyses of 6 and 12 months cohorts of patients
initiating ART (Table 5), availability of .2 vs. #2 adherence
support services had significantly lower cohort attrition at 6
months (RRadj = 0.84, 95%CI: 0.73–0.96), but not 12 months
following ART initiation. Cohorts of patients initiating ART at
clinics offering pharmacy services including routine medication
pickup review were significantly associated with lower attrition at 6
months and marginally lower attrition at 12 months, respectively
(RRadj,6m = 0.78, 95%CI: 0.69–0.90; RRadj,12m = 0.85, 95%CI:
0.73–1.0). Cohorts of patients initiating ART at clinics with active
patient outreach had lower attrition at 6 and 12 months
(RRadj,6m = 0.86, 95%CI: 0.73–0.99; RRadj,12m = 0.84, 95%CI:
0.74–0.96, respectively). Availability of other services were not
significantly associated with 6 or 12 month attrition among cohorts
of patients initiating ART.

Adjustment for Multiple Adherence Support Services
In the ‘‘full’’ model including all services significant at an alpha
level of 0.1 (Table 6), availability of educational materials and food
rations remained significantly associated with lower rates of total
attrition and LTF, while availability of on-site support groups and
reminder tools remained significantly associated with lower death
rates.
For the ART cohort analysis, in the ‘‘full’’ model including all
adherence support services significant at an alpha level of 0.1
(Table 7), availability of pharmacy services remained significantly
associated with lower attrition at 6 months, while availability of
active patient outreach remained significantly associated at 12 but
PLoS ONE | www.plosone.org
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yes vs. no
yes vs. no

on-site support groups for HIV+
patients

Peer educator program

8
yes vs. no

yes vs. no

185/164

60/289

278/71

0.97

0.83

0.61

0.79

0.83

1.10

1.06

0.58

0.51

Crude
(95%CI)

(0.82–1.14)

(0.66–1.03)

(0.42–0.91)

(0.64–0.98)

(0.72–0.96)

(0.95–1.27)

(0.89–1.25)

(0.4–0.86)

(0.31–0.85)

1.00

0.72

0.71

0.79

0.73

0.99

1.03

0.62

0.59

(0.85–1.18)

(0.58–0.9)

(0.48–1.05)

(0.64–0.97)

(0.63–0.85)

(0.86–1.14)

(0.87–1.22)

(0.42–0.92)

(0.35–1.0)

Adjusted4
(95%CI)

Overall Attrition1 Rate Ratio

1.03

0.66

0.59

0.79

0.69

1.16

1.24

0.52

0.45

Crude
(95%CI)

(0.83–1.28)

(0.49–0.9)

(0.36–0.96)

(0.6–1.05)

(0.57–0.83)

(0.96–1.4)

(0.99–1.55)

(0.32–0.84)

(0.24–0.84)

1.05

0.65

0.60

0.77

0.63

1.08

1.20

0.55

0.48

(0.84–1.32)

(0.47–0.88)

(0.36–1)

(0.58–1.02)

(0.52–0.77)

(0.89–1.32)

(0.95–1.52)

(0.33–0.89)

(0.25–0.92)

Adjusted4
(95%CI)

Overall Loss to Follow-up2 Rate Ratio

0.87 (0.74–1.02)

1.16 (0.95–1.41)

0.68 (0.45–1.03)

0.79 (0.63–0.99)

1.19 (1.02–1.4)

0.98 (0.85–1.14)

0.80 (0.69–0.94)

0.75 (0.48–1.17)

0.7 (0.38–1.28)

Crude
(95%CI)

0.91

0.83

0.95

0.81

0.98

0.84

0.81

0.82

0.94

(0.79–1.06)

(0.69–1)

(0.66–1.37)

(0.66–0.98)

(0.85–1.13)

(0.74–0.96)

(0.7–0.93)

(0.55–1.21)

(0.55–1.61)

Adjusted4 (95%CI)

Overall Death3 Rate Ratio

3

2

Overall attrition rates estimated as the cumulative number of patients at a site lost to follow-up, withdrawn, or reported dead, over the total person-years observed on ART at that site.
Overall loss to follow-up rates estimated as the cumulative number of patients not returning to clinic for .6 months since last visit, with no known status, over the total person-years observed on ART at that site.
Overall death rates estimated as the cumulative number of patients reported dead, over the total person-years observed on ART at that site.
4
Adjusted for facility type (primary, secondary, or tertiary), urban/rural, year facility began providing ART care, and cumulative number of patients seen in care.
doi:10.1371/journal.pone.0038443.t004

1

Active patient outreach

Outreach Services

Food rations to promote ART
adherence

Structural services

Routine medication pickup review,
dedicated or team pharmacist

yes vs. no

245/104

Reminder tools (e.g., clocks, calendars, yes vs. no
pill boxes)

Pharmacy services

199/150

150/199

190/159

308/41

292/57

N (yes/no)

yes vs. no

Educational materials promoting ART
adherence

Informational services

yes vs. no

.2 vs. #2

One-on-one/group adherence
counseling services

Directed support services

Total number of adherence support
services provided

Adherence support services

Facility-Level Characteristics

Table 4. Crude and Adjusted overall Rate Ratios for attrition, loss to follow-up, and death.
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yes vs. no
yes vs. no

peer educator program

9
yes vs. no

yes vs. no

725/363

178/919

1027/61

978/110

773/315

476/612

679/409

685/403

1016/81

N (yes/no)

0.83

0.89

0.80

1.04

1.01

0.93

0.91

1.13

0.82

(0.71–0.96)

(0.7–1.13)

(0.68–0.93)

(0.67–1.61)

(0.84–1.21)

(0.74–1.17)

(0.72–1.14)

(1.01–1.26)

(0.71–0.95)

Crude RR (95%CI)

0.85

0.82

0.78

1.03

0.97

0.93

0.90

1.07

0.84

3

2

(0.73–0.99)

(0.64–1.05)

(0.69–0.9)

(0.7–1.51)

(0.81–1.17)

(0.77–1.12)

(0.74–1.1)

(0.96–1.2)

(0.73–0.96)

Adjusted3 RR (95%CI)

Attrition Risk Ratio through 6 months1

Cohort attrition % estimated as 100 - (number of patients on ART through 6 months/number starting cohort at baseline).
Cohort attrition % estimated as 100 - (number of patients on ART through 12 months/number starting cohort at baseline).
Adjusted for facility type (primary, secondary, or tertiary), urban/rural, cohort start year, and cumulative number of patients seen in care.
4
All analyses adjusting for within-site correlation using generalized estimating equations.
doi:10.1371/journal.pone.0038443.t005

1

Active patient outreach

Outreach Services

Food rations to promote ART adherence

Structural services

Routine medication pickup review, dedicated or
team pharmacist

yes vs. no

yes vs. no

Reminder tools (e.g., clocks, calendars, pill boxes)

Pharmacy services

yes vs. no

Educational materials promoting ART adherence

Informational services

yes vs. no

on-site support groups for HIV+ patients

.2 vs. #2

one–on-one/group adherence counseling

Directed support services

Total number of adherence support services
provided

Adherence support services

Facility-Level Characteristics

Table 5. Cohort analysis4: Crude and Adjusted Risk Ratios for attrition through 6 and 12 months.

0.81

1.01

0.89

1.03

1.05

0.97

0.92

1.28

0.9

(0.71–0.91)

(0.81–1.25)

(0.77–1.03)

(0.79–1.36)

(0.91–1.21)

(0.8–1.17)

(0.77–1.11)

(1.12–1.45)

(0.76–1.07)

Crude RR (95%CI)

0.84

0.98

0.85

1.02

1.02

0.94

0.89

1.22

0.89

(0.74–0.96)

(0.78–1.21)

(0.73–1)

(0.8–1.29)

(0.87–1.19)

(0.81–1.1)

(0.77–1.03)

(1.1–1.36)

(0.75–1.05)

Adjusted3 RR (95%CI)

Attrition Risk Ratio through 12 months2
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Table 6. ‘‘Full’’ model analysis: Risk and Rate Ratios for overall attrition, LTF and death adjusting for other adherence support
activities1.

Adherence support services

Attrition Rate Ratio2

LTF Rate Ratio2

Death Rate Ratio2
not in model

one-on-one/group adherence counseling

yes vs. no

0.77 (0.52–1.14)

0.72 (0.44–1.19)

on-site support groups for HIV+ patients

yes vs. no

not in model

not in model

0.82 (0.69–0.99)

peer educator program

yes vs. no

not in model

not in model

0.89 (0.76–1.05)

Educational materials promoting ART adherence

yes vs. no

0.76 (0.66–0.89)

0.67 (0.55–0.81)

not in model

Reminder tools (e.g., clocks, calendars, pill boxes)

yes vs. no

0.83 (0.67–1.03)

0.83 (0.63–1.11)

0.78 (0.64–0.94)

Routine medication pickup review, dedicated
or team pharmacist

yes vs. no

0.92 (0.62–1.38)

0.85 (0.50–1.42)

not in model

Food rations to promote ART adherence

yes vs. no

0.74 (0.60–0.92)

0.67 (0.49–0.91)

0.86 (0.71–1.04)

Active patient outreach program

yes vs. no

not in model

not in model

1.12 (0.93–1.34)

1
All models adjusted for year of ART initiation, facility type (primary, secondary, tertiary), facility location (urban/rural), and cumulative number of patients enrolled in
care.
2
Rate ratios for total attrition, loss to follow-up, and death additionally adjusted for other adherence support and active outreach services listed in the above table.
doi:10.1371/journal.pone.0038443.t006

due to different definitions for these outcomes in the two types of
analyses we utilized (cumulative estimates, which carry with them
a clinic’s entire history with respect to retention and survival, and
cohort-estimates, which provide more time-defined estimates).
For specific adherence support services (adherence counseling
services, educational materials, and reminder tools) associations
were observed with lower attrition in the cumulative analyses but
not in the 6- and 12-month ART cohort analyses. It is important
to note that, as highlighted in Figure 1 and above, the cumulative
attrition rates are averages over an entire clinic’s reporting history,
and more weight is given to quarters in which more patients were
active in care. Although this average estimate accurately reflects
the average attrition rate for each clinic, it may not accurately
represent attrition rates at any one point in time, especially among
clinics experiencing rapid scale-up during the time period if this
scale up was also coupled with changing attrition. In contrast,
cohort attrition proportions estimate 6 and 12 month attrition
after ART initiation by following specific groups of patients
initiating ART in the same time period. Reporting on longitudinal
cohorts of patients initiating ART in a given time period and
followed up for 6 and 12 months is inherently a more difficult task
to complete, and not all clinics have the capability of doing this, or
were able to do this for the full population included in the
cumulative analysis. Thus, cohorts that were reported and thus
included in this analysis may be more similar in other aspects
impacting retention (such as proper reporting systems in place)
regardless of availability of these specific services such that

estimates of the proportion dead among patients LTF, obtained
through tracing studies or simulation, would help clarify the
complex relationship between LTF and death ascertainment.
Malnutrition and wasting have been associated with unfavorable HIV disease outcomes [14,40,41], and food insecurity may
adversely affect HIV related outcomes from two perspectives: as
a possible reason for non-adherence to ART (fear of hunger and
actual hunger coupled with food insecurity [13]) as well as a
structural barrier to retention [42,43] (lost wages from attending
clinic). In our analyses, clinics with availability of food rations
had significantly lower attrition and LTF rates in the cumulative
analysis, but had only a marginal effect on death rates, the latter
effect not retained in the full model analysis. It is possible that
under-ascertainment of deaths at facilities with higher LTF could
mask the true impact of food support services on survival. In the
cohort analyses, similar-magnitude but non-significant associations (compared to the cumulative analysis) were observed for
attrition at 6 months, but not 12 months. The inconsistent
findings may reflect unmeasured confounding (perhaps the 17%
of the clinics offering food rations were more likely to offer other
[unmeasured] services improving retention) or inconsistency
between cumulative and cohort-derived measures of retention.
Availability of services to track patients missing visits has been
associated with reduced LTF [14,44–46]. In our analyses,
however, clinics with availability of active outreach services did
not have lower attrition, LTF or death rates in the cumulative
analysis but they did have significantly lower attrition in the 12
month cohort analysis. The reason for this discrepancy may be

Table 7. ART cohort ‘‘full model’’ analysis: Adjusted1 Attrition Risk Ratio at 6 and 12 months, adjusting for other adherence
support activities

Adherence support services

Attrition % through 6 months

Attrition % through 12 months

RR1

RR1

Routine medication pickup review, dedicated
or team pharmacist

yes vs. no

0.81 (0.70–0.94)

0.87 (0.73–1.04)

Food rations to promote ART adherence

yes vs. no

0.87 (0.67–1.12)

1.04 (0.83–1.31)

Active patient outreach program

yes vs. no

0.87 (0.75–1.12)

0.84 (0.73–0.96)

1

Percent attrition ratios (RRs) additionally adjusted for other adherence support and active outreach services listed in the above table.
doi:10.1371/journal.pone.0038443.t007
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associations observed in the cumulative clinic-level analyses can in
fact differ from those observed in the cohort analyses.
Our study has a number of strengths. The use of routinely
collected programmatic data enabled inclusion of a large number
of patients from diverse HIV care and treatment clinics from 10
sub-Saharan African countries, representing approximately 8% of
all patients initiating ART in this region and time [47]. The large
number of clinics and contexts enabled examination of many
clinic-level characteristics. Our findings were robust to sensitivity
analyses, including exclusion of individual countries and cohorts
that initiated ART in 2004 and 2005. Finally, the use of two
different types of outcomes for retention (cumulative and cohortbased measures) allows examination of the findings in the context
of the different limitations inherent in each approach.
There are also several limitations to our analyses. This was an
ecologic analysis of the impact of programmatic factors on
attrition, and therefore cannot adjust for differences in patient
characteristics across clinics and cohorts that also impact attrition,
such as CD4 count at ART initiation [38,48]. However, we also
note that programmatic factors likely act at least in part through
their impact on these individual-level factors. Additionally, our
analyses focused on reported presence or absence of various
services at clinics, and we are unable to investigate key issues such
as intensity and coverage of these services, per-patient service
frequency, or quality of the services provided. Also, while our
patient population consisted primarily of adults, 8% of our
population was pediatric patients, who may have different
determinants of attrition, LTF, and death. Due to limitations in
the routinely-collected data, we were unable to separate out our
aggregate population into adults and children. Also, while the
population of patients included in this report was followed between
2004 and 2008, clinic interviews for availability of services were
conducted in 2007 and 2008; some clinics with a different service
availability profile prior to the initial 2007 assessment may be
misclassified for part of the analysis period. Reported deaths could
not be confirmed and, as noted above, the lack of complete vital
status ascertainment in the context of high rates of LTF, warrants
caution in interpretation of associations with death rates. We
therefore place greater emphasis on the combined outcome of
attrition when assessing programmatic outcomes. For the cumulative clinic-level attrition analyses, we note that data collected
over several years, used to calculate an overall average attrition
rate for each facility, may be subject to variable quality. Although
standardized data quality measures are in place at all clinics, and
data are reviewed routinely for errors and inconsistencies, it is
possible that the quality of the data, particularly recording of loss
to follow-up and mortality, differed within clinics across this time
period. We have no information to assess this possibility and this is
an important potential source of information bias in our
assessments. Finally, we note in Table 3 that the availability of

specific adherence support and outreach services is not distributed
randomly across all clinics: clinics reporting availability of one
service tend to be more likely to offer additional services as well.
While we accounted for this by (1) testing whether the presence of
more than 2 services was associated with attrition, LTF, and death
and (2) reporting on measures of association between specific
adherence services and these outcomes adjusting for other service
availability (Table 6), we acknowledge that co-linearity between
availability of support services limits our ability to separate out the
association of specific services.
In summary, acknowledging the important limitations discussed
above, our findings provide insights into the association between
the availability of various adherence support and outreach
activities and retention on ART in HIV programs in sub-Saharan
Africa. Further analyses using patient-level information and
measures of service utilization and quality would add further to
this study. However, a substantial proportion of sub-Saharan HIV
clinics do not have electronic patient-level data systems available,
and findings from such analyses may be less generalizable to HIV
scale-up clinics in the region. Thus broad ecological analyses of
service delivery data and analyses that utilize individual-level
information should be leveraged to provide complimentary
insights. Our analyses demonstrate the utility of routinely-collected
aggregate data for informing program evaluation and design, and
suggest that availability of adherence support services, active
patient outreach, and food rations at HIV care clinics may
improve retention following ART initiation.
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